Jubilant Pharmova Limited (JUBLPHARMA.NS)

Home
JUBLPHARMA.NS
Financials

1239 (INR) • At close November 8, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003
Revenue Numbers are in millions	67,029	62,193	60,591.65	59,638.76	89,765.37	89,970.88	74,247.76	57,652.75	57,004.5	57,761.38	57,216.13	51,429.9	43,031.26	34,334.04	37,812.72	35,179.84	24,888.77	18,097.15	15,053.5	11,702.65	8,592.01
Cost of Revenue Numbers are in millions	47,386	18,779.3	17,869.88	17,534.52	34,544.7	38,212.55	31,435.19	22,521.69	23,708.8	29,184.56	26,869.98	20,500.46	22,317.56	13,695.01	30,458.07	16,395.26	11,691.53	9,689.35	12,883.04	6,611.87	4,379.41
Gross Profit Numbers are in millions	19,643	43,413.7	42,721.77	42,104.24	55,220.67	51,758.33	42,812.57	35,131.06	33,295.7	28,576.82	30,346.15	30,929.44	20,713.7	20,639.03	7,354.65	18,784.58	13,197.24	8,407.8	2,170.46	5,090.78	4,212.6
Gross Profit Ratio Numbers are in millions	0.293	0.698	0.705	0.706	0.615	0.575	0.577	0.609	0.584	0.495	0.53	0.601	0.481	0.601	0.195	0.534	0.53	0.465	0.144	0.435	0.49
Reseach & Development Expenses Numbers are in millions	148	0	0	0	185.05	202.2	182.05	161.64	131.16	71.6	0	0	0	0	0	0	0	0	0	0	0
General & Administrative Expenses Numbers are in millions	22,209	2,230.78	2,457.96	2,322.6	2,464.69	2,675.91	1,459.12	1,023.26	971.38	1,235.83	1,056.4	7,636.55	1,917.34	3,674.65	0	4,223.55	3,344.07	2,701.74	0	1,863.6	1,462.94
Selling & Marketing Expenses Numbers are in millions	664	1,526.51	1,559.24	1,490.51	2,318.88	2,176.8	1,957.95	1,331.63	1,202.87	1,283.7	1,608.89	1,232.82	1,120.97	1,624.31	0	1,177.72	948.66	785.09	0	467.81	319.33
SG&A Numbers are in millions	14,454	3,757.29	4,017.2	3,813.11	4,783.57	4,852.71	3,417.07	2,354.89	2,174.25	2,519.53	2,665.29	8,869.37	3,038.31	5,298.96	0	5,401.27	4,292.73	3,486.83	0	2,331.41	1,782.27
Other Expenses Numbers are in millions	687	383.3	86.9	67.18	115.14	125.48	226.88	159.32	109.04	134.08	113.58	175.45	-39.53	11,595.47	670.48	7,885.88	3,999.22	2,567.82	316.41	1,316.53	1,120.12
Operating Expenses Numbers are in millions	14,454	41,191.5	34,477.26	30,917.52	40,341.51	37,937.82	31,738.15	24,398.27	23,888.08	24,552.57	23,065.56	22,830.68	13,841.14	16,894.43	670.48	13,287.15	8,291.95	6,054.65	316.41	3,647.94	2,902.39
Operating Income Numbers are in millions	5,189	3,748.77	8,398.34	11,442.53	12,387.29	13,820.51	11,074.42	10,732.79	9,407.62	4,024.25	7,280.59	8,098.76	6,872.56	3,744.6	6,684.17	5,497.43	4,905.29	2,353.15	1,854.05	1,442.84	1,310.21
Operating Income Ratio Numbers are in millions	0.077	0.06	0.139	0.192	0.138	0.154	0.149	0.186	0.165	0.07	0.127	0.157	0.16	0.109	0.177	0.156	0.197	0.13	0.123	0.123	0.152
Total Other Income Expenses Net Numbers are in millions	-3,725	-3,470.96	-2,093.87	-2,731.77	-2,258.54	-4,782.4	-2,483.6	-3,356.37	-3,564.24	-3,621.01	-5,207.76	-4,687.38	-5,731.49	-1,338.69	-1,505.2	-2,531.67	-343.98	599.89	-172.66	198.4	-343.93
Income Before Tax Numbers are in millions	1,464	277.8	6,304.47	8,710.76	12,105.31	9,038.11	8,590.82	7,376.42	5,843.38	403.24	2,072.83	3,411.38	1,141.07	2,405.91	5,178.97	2,965.76	4,561.31	2,953.04	1,681.39	1,641.24	966.28
Income Before Tax Ratio Numbers are in millions	0.022	0.004	0.104	0.146	0.135	0.1	0.116	0.128	0.103	0.007	0.036	0.066	0.027	0.07	0.137	0.084	0.183	0.163	0.112	0.14	0.112
Income Tax Expense Numbers are in millions	978	926.6	2,174.31	2,972.18	3,122.88	3,268.03	2,246.64	1,630.16	1,528.53	804.84	696.44	1,523.6	684.14	133.65	959.44	-267.19	-572.84	-712.49	392.44	-431.59	-179
Net Income Numbers are in millions	771	-609.8	4,139.36	8,358.69	8,982.46	5,744.56	6,428.06	5,756.53	4,314.85	-577.64	1,090.4	1,527.27	145.61	2,297.19	4,214.61	2,831.76	4,004.94	2,280	1,296.75	1,191.93	782.37
Net Income Ratio Numbers are in millions	0.012	-0.01	0.068	0.14	0.1	0.064	0.087	0.1	0.076	-0.01	0.019	0.03	0.003	0.067	0.111	0.08	0.161	0.126	0.086	0.102	0.091
EPS Numbers are in millions	4.87	-3.83	26.01	52.48	56.39	36.1	41.25	36.93	25.1	-3.63	6.85	9.59	0.91	14.42	28.56	18.3	26.5	15.17	9.03	9.41	6.35
EPS Diluted Numbers are in millions	4.86	-3.83	26.01	52.48	56.39	36.1	41.25	36.91	25.08	-3.63	6.85	9.59	0.91	13.04	24.66	15.77	21.35	12.4	8.16	8.9	6.35
EBITDA Numbers are in millions	9,008	8,268.3	11,536.15	15,211.8	19,825.77	17,749.03	15,328.78	13,362.22	12,642.07	6,823.56	10,084.99	10,605.72	9,444.59	5,385.42	7,931.01	7,072.86	6,408.72	2,944.33	2,390.91	1,816.29	1,624.38
EBITDA Ratio Numbers are in millions	0.134	0.133	0.19	0.255	0.221	0.197	0.206	0.232	0.222	0.118	0.176	0.206	0.219	0.157	0.21	0.201	0.257	0.163	0.159	0.155	0.189

Jubilant Pharmova Limited

NSE:JUBLPHARMA.NS Add to watchlist

NSE:JUBLPHARMA.NS